Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.

Research square·2025
Same author

Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma.

Nature communications·2025
Same author

Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment.

Blood cancer journal·2025
Same author

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

The New England journal of medicine·2024
Same author

Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas.

Virchows Archiv : an international journal of pathology·2023

Related Experiment Video

Updated: May 8, 2026

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

Inflammatory pathways in spondyloarthritis.

Hulda S Hreggvidsdottir1, Troy Noordenbos, Dominique L Baeten

  • 1Department of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Tytgat Institute for Liver and Intestinal Research, Academic Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Molecular Immunology
|August 24, 2013
PubMed
Summary

Spondyloarthritis involves new bone growth. Different forms of TNF and the IL-23/IL-17 pathway contribute to this, offering new therapeutic targets for ankylosing spondylitis.

Keywords:
Ankylosing spondylitisCytokinesIL-23SpondyloarthritisTNF

More Related Videos

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
04:47

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis

Published on: October 27, 2023

Related Experiment Videos

Last Updated: May 8, 2026

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:18

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue

Published on: February 24, 2023

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
04:47

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis

Published on: October 27, 2023

Area of Science:

  • Immunology
  • Rheumatology
  • Genetics

Background:

  • Spondyloarthritis (SpA) is a common inflammatory arthritis characterized by new bone formation.
  • Cytokine pathways, including TNF and IL-23/IL-17, are implicated in SpA pathogenesis, particularly ankylosing spondylitis (AS).

Purpose of the Study:

  • To review recent genetic associations and experimental data on cytokine pathways in SpA.
  • To discuss the role of these pathways in SpA pathophysiology and new bone formation.

Main Methods:

  • Review of genetic association studies.
  • Analysis of experimental data from animal models.
  • Examination of human in vivo data.

Main Results:

  • Transmembrane TNF overexpression models show axial and peripheral new bone formation, distinct from soluble TNF.
  • The IL-23/IL-17 axis is increasingly recognized, with genetic links and therapeutic potential in AS.
  • Multiple cytokine pathways (TNF, IL-1, IL-6, IL-23/IL-17) are involved in SpA.

Conclusions:

  • Distinct roles for soluble and transmembrane TNF in SpA bone formation.
  • The IL-23/IL-17 pathway is a significant factor in AS development and progression.
  • Understanding these cytokine pathways is crucial for targeting SpA pathophysiology and new bone formation.